Related Experiment Video
Updated: Sep 17, 2025

Knee Arthrocentesis in Adults
Published on: February 25, 2022
Chronic Anticoagulation is Associated With Significantly Increased Rates of Medical Complications, Periprosthetic
Rahul K Goel1,2, Bailey J Ross1, Kevin Y Heo1
1Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA.
Insights
Patients on chronic anticoagulation (CA) face higher risks of complications, including sepsis, infection, and revision surgery, after total knee arthroplasty (TKA). Careful preoperative and perioperative management is crucial for this growing patient group.
Area of Science:
- Orthopedic Surgery
- Pharmacology
- Public Health
Background:
- The number of patients requiring total knee arthroplasty (TKA) while on chronic anticoagulation (CA) is rising.
- Limited research exists on the complication rates associated with TKA in patients on CA.
Purpose of the Study:
- To compare complication rates after primary TKA between patients on chronic anticoagulation (CA) and those not on CA.
Main Methods:
- A retrospective cohort study utilized IBM MarketScan databases.
- Patients undergoing primary TKA were divided into CA and control groups based on anticoagulant use.
- Complication rates (readmissions, medical complications, PJI, revision) were compared using multivariable logistic regression.
Main Results:
- The CA cohort (7.7% of 181,760 patients) showed significantly higher rates of sepsis, hematoma, wound dehiscence, and readmission within 90 days.
- At 2 years, the CA cohort had significantly higher rates of periprosthetic joint infection (PJI) and all-cause revision.
Conclusions:
- Chronic anticoagulation (CA) is linked to increased risks of readmission, medical complications, PJI, and revision after primary TKA.
- Preoperative medical optimization and perioperative management are critical for patients on CA undergoing TKA.
Background:
The proportion of patients undergoing total knee arthroplasty (TKA) who are on chronic anticoagulation (CA) is increasing. As existing literature is limited, the purpose of this study was to compare complication rates after primary TKA among patients who were vs were not on CA.
Methods:
This is a retrospective cohort study using the IBM MarketScan databases. Patients who underwent primary TKA were dichotomized into the CA or control cohort based upon the presence or absence, respectively, of claims for direct oral anticoagulants, warfarin, or low-molecular-weight heparin within 6 months both before and after TKA. Rates of readmissions, medical complications within 90 days, periprosthetic joint infection (PJI), and all-cause revision at 2 years were compared with multivariable logistic regression.
Results:
A total of 181,760 patients met inclusion criteria, including 13,967 (7.7%) on CA. At 90 days, the CA cohort exhibited significantly higher rates of sepsis (0.9 vs 2.2%; odds ratio (OR) 1.7; P < .001), hematoma (0.3 vs 0.7%; OR 1.7; P < .001), wound dehiscence (1.2 vs 2.1%; OR 1.4; P < .001), and readmission (6.1 vs 14.2%; OR 2.5; P < .001). At 2 years, rates of PJI (0.4 vs 1.1%; OR 2.4; P < .001) and all-cause revision (2.3 vs 3.4%; OR 1.5; P < .001) were significantly higher in the CA cohort.
Conclusions:
CA was associated with significantly higher rates of readmission, medical complications, PJI, and all-cause revision after primary TKA. This data highlights the importance of preoperative medical optimization and perioperative medical management in this population.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Endocarditis III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management

